PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer
Resource Type
Article
Authors
Evrard, Camille ; Louvet, Christophe ; Hajbi, Farid EL ; Fiore, Frédéric DI ; Malicot, Karine LE ; Aparicio, Thomas ; Bouché, Olivier ; Laurent-Puig, Pierre ; Bibeau, Frédéric ; Lecomte, Thierry ; Lièvre, Astrid ; Guimbaud, Rosine ; Kim, Stefano ; Zaanan, Aziz ; Sokol, Harry ; Chibaudel, Benoist ; Desrame, Jérome ; Pierre, Sabrina ; Gonzalez, Daniel ; Lepage, Come ; Tougeron, David
Source
In Digestive and Liver Disease April 2021 53(4):420-426
Subject
Language
ISSN
1590-8658